🇺🇸 FDA

Intelligence · Clinical Pipeline

BRIGHT MINDS BIOSCIENCES Pipeline

All ClinicalTrials.gov programs at BRIGHT MINDS BIOSCIENCES — phase, modality, and trial IDs.

Programs
1,063

Quick answer

BRIGHT MINDS BIOSCIENCES has 1,063 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. CDD-2101

    BRIGHT MINDS BIOSCIENCES INC.

    Constipation - Functional

    phase 1 small molecule completed

    1 trial

  2. CI-581a

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Dependence

    phase 1 small molecule completed

    1 trial

  3. CS-1103

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorders

    phase 1 small molecule completed

    1 trial

  4. CVL-354

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 1 small molecule completed

    1 trial

  5. CVL-354

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  6. Cannabidiol, Medium Dose

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis

    phase 1 small molecule active

    1 trial

  7. Cannabis

    BRIGHT MINDS BIOSCIENCES INC.

    Pain

    phase 1 small molecule active

    2 trials

  8. Cannabis

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Intoxication

    phase 1 small molecule active

    2 trials

  9. Cannabis Cigarette

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Use

    phase 1 small molecule completed

    1 trial

  10. Cannabis sativa Extract

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Dependence

    phase 1 small molecule active

    1 trial

  11. Carbon Monoxide inhalation

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    phase 1 small molecule terminated

    1 trial

  12. Cigarette

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoker

    phase 1 small molecule completed

    1 trial

  13. Clarithromycin

    BRIGHT MINDS BIOSCIENCES INC.

    Drug-induced QT Prolongation

    phase 1 small molecule completed

    1 trial

  14. Clavulanic Acid

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence, in Remission

    phase 1 small molecule completed

    1 trial

  15. Clavulanic acid

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 1 small molecule completed

    1 trial

  16. Cocaine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Abuse

    phase 1 small molecule completed

    1 trial

  17. Cocaine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule completed

    3 trials

  18. Cocaine (IV)

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 1 small molecule active

    1 trial

  19. Cocaine Self-adminstration

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 1 small molecule completed

    1 trial

  20. Cocaine hydrochloride

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Induced Sympathoexciation and Vasoconstriction

    phase 1 small molecule terminated

    1 trial

  21. Cognitive-Behavioral Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Dependence

    phase 1 other completed

    1 trial

  22. Cohort 1 - TMP-301

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule completed

    1 trial

  23. Cycloserine

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Addiction

    phase 1 small molecule completed

    1 trial

  24. Cypep-1

    BRIGHT MINDS BIOSCIENCES INC.

    Cutaneous Warts

    phase 1 small molecule completed

    1 trial

  25. DF-003

    BRIGHT MINDS BIOSCIENCES INC.

    ROSAH

    phase 1 small molecule active

    1 trial

  26. Dabigatran

    BRIGHT MINDS BIOSCIENCES INC.

    Mild Cognitive Impairment

    phase 1 small molecule terminated

    1 trial

  27. Delta-9-THC Low Dose

    BRIGHT MINDS BIOSCIENCES INC.

    Age-related Cognitive Decline

    phase 1 small molecule active

    1 trial

  28. Dihydrexidine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 1 small molecule active

    1 trial

  29. Disulfiram

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 1 small molecule completed

    1 trial

  30. Divalproex Sodium Extended-release 250mg

    BRIGHT MINDS BIOSCIENCES INC.

    Epilepsy

    phase 1 small molecule active

    1 trial

  31. Dociparstat sodium

    BRIGHT MINDS BIOSCIENCES INC.

    Acute Myeloid Leukemia

    phase 1 small molecule completed

    1 trial

  32. Dofetilide

    BRIGHT MINDS BIOSCIENCES INC.

    Drug-induced QT Prolongation

    phase 1 small molecule completed

    1 trial

  33. Dronabinol

    BRIGHT MINDS BIOSCIENCES INC.

    Bipolar Disorder

    phase 1 small molecule terminated

    1 trial

  34. Dronabinol

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    phase 1 small molecule completed

    1 trial

  35. Dronabinol Capsules

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 1 small molecule active

    1 trial

  36. Drug A (Blinded Drug)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 1 small molecule on hold

    1 trial

  37. EBC-129

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Solid Tumours

    phase 1 small molecule active

    1 trial

  38. ECHO (Empowering Our Community & Health Outcomes)

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 1 other terminated

    1 trial

  39. ECIG liquid vehicles

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Exposure

    phase 1 other completed

    1 trial

  40. ENA-001

    BRIGHT MINDS BIOSCIENCES INC.

    Respiratory Depression

    phase 1 small molecule active

    1 trial

  41. ETC-159

    BRIGHT MINDS BIOSCIENCES INC.

    With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer

    phase 1 small molecule active

    1 trial

  42. ETC-1907206

    BRIGHT MINDS BIOSCIENCES INC.

    Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)

    phase 1 small molecule terminated

    1 trial

  43. ETC-1922159

    BRIGHT MINDS BIOSCIENCES INC.

    Solid Tumors

    phase 1 small molecule active

    1 trial

  44. ETR028, ETR029, [ETR028 + ETR029] or HCBT

    BRIGHT MINDS BIOSCIENCES INC.

    Acute Pain

    phase 1 small molecule active

    1 trial

  45. Empagliflozin 10 MG Oral Tablet [Jardiance]

    BRIGHT MINDS BIOSCIENCES INC.

    Diabetes Mellitus

    phase 1 small molecule completed

    1 trial

  46. Epidiolex

    BRIGHT MINDS BIOSCIENCES INC.

    CBD

    phase 1 small molecule active

    1 trial

  47. Evaluate the effects of Environmental Enrichment (EE) on alcohol consumption

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol Use Disorder

    phase 1 other active

    1 trial

  48. Evolocumab

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Subjects

    phase 1 mab completed

    1 trial

Frequently asked questions

How many pipeline programs does BRIGHT MINDS BIOSCIENCES have?

1,063 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.